Agios Pharmaceuticals, Inc. (AGIO) NASDAQ
35.20
+1.01(+2.95%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
35.20
+1.01(+2.95%)
Currency In USD
| Market Cap | 1.58B |
| Enterprise Value | 1.55B |
| P/E Ratio | -4.98 |
| PEG Ratio | 2.16 |
| Price/Sales Ratio | 38.17 |
| Price/Book Ratio | 1.72 |
| Enterprise/Revenue | 37.27 |
| Enterprise/EBITDA | -4.59 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -7.64 |
| Operating Margin | -8.74 |
| Return On Assets | -0.32 |
| Return On Equity | -0.31 |
| Revenue | 54.03M |
| Revenue/Share | 0.93 |
| Gross Profit | 47.68M |
| EBITDA | -466.96M |
| Net Income | -412.78M |
| Diluted EPS | -7.12 |
| Total Cash | 854.43M |
| Total Cash/Share | 14.64 |
| Total Debt | 40.21M |
| Total Debt/Equity | 0.03 |
| Current Ratio | 11.46 |
| Book Value Per Share | 20.45 |
| 52-Week Change | 36.65 |
| 52-Week High | 46 |
| 52-Week Low | 22.24 |
| Moving Average 50 Days | 28.76 |
| Moving Average 200 Days | 33.78 |
| Average Volume | 931,309 |
| Shares Outstanding | 58.59M |
| % Held by Institutions | 105.37 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |